epibatidine has been researched along with oxidopamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, PB; Cumming, P; Pradhan, AA | 1 |
| Ahtee, L; Janhunen, S; Tuominen, RK | 1 |
| Huang, LZ; Quik, M; Riveles, K | 1 |
| Grady, SR; Huang, LZ; Quik, M | 1 |
4 other study(ies) available for epibatidine and oxidopamine
| Article | Year |
|---|---|
[125I]Epibatidine-labelled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents.
Topics: 5,7-Dihydroxytryptamine; Afferent Pathways; Animals; Autoradiography; Bridged Bicyclo Compounds, Heterocyclic; Carrier Proteins; Cerebral Cortex; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Iodine Radioisotopes; Male; Medial Forebrain Bundle; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Neurotoxins; Nicotinic Agonists; Nucleus Accumbens; Olfactory Pathways; Oxidopamine; Pyridines; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins | 2002 |
Comparison of the effects of nicotine and epibatidine given in combination with nomifensine on rotational behaviour in rats.
Topics: Adrenergic Agents; Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Male; Motor Activity; Nicotine; Nicotinic Agonists; Nomifensine; Oxidopamine; Parkinsonian Disorders; Pyridines; Rats; Rats, Wistar | 2005 |
Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Catecholamines; Cell Count; Cell Differentiation; Cell Line; Cell Survival; Cotinine; Humans; Immunohistochemistry; Neuroprotective Agents; Nicotiana; Nicotine; Nicotinic Agonists; Oxidopamine; Phenotype; Pyridines; Receptors, Nicotinic; Smoke; Smoking; Tyrosine 3-Monooxygenase | 2008 |
Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors.
Topics: Animals; Antiparkinson Agents; Autoradiography; Bridged Bicyclo Compounds, Heterocyclic; Corpus Striatum; Cotinine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Functional Laterality; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nicotinic Agonists; Oxidopamine; Pyridines; Receptors, Nicotinic; Substantia Nigra; Sympatholytics | 2011 |